These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37473460)

  • 1. Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9.
    Ben Yacoub T; Letellier C; Wohlschlegel J; Condroyer C; Slembrouck-Brec A; Goureau O; Zeitz C; Audo I
    Stem Cell Res; 2023 Sep; 71():103166. PubMed ID: 37473460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother.
    Wohlschlegel J; Letellier C; Liu B; Méjécase C; Slembrouck-Brec A; Condroyer C; Michiels C; Sahel JA; Reichman S; Zeitz C; Goureau O; Audo I
    Stem Cell Res; 2019 Dec; 41():101625. PubMed ID: 31731182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines.
    Amprou A; Yacoub TB; Letellier C; Degaetano V; Méjécase C; Pormehr LA; Condroyer C; Slembrouck-Brec A; Wohlschlegel J; Goureau O; Zeitz C; Audo I
    Stem Cell Res; 2024 Dec; 81():103558. PubMed ID: 39293306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The familial dementia gene revisited: a missense mutation revealed by whole-exome sequencing identifies ITM2B as a candidate gene underlying a novel autosomal dominant retinal dystrophy in a large family.
    Audo I; Bujakowska K; Orhan E; El Shamieh S; Sennlaub F; Guillonneau X; Antonio A; Michiels C; Lancelot ME; Letexier M; Saraiva JP; Nguyen H; Luu TD; Léveillard T; Poch O; Dollfus H; Paques M; Goureau O; Mohand-Saïd S; Bhattacharya SS; Sahel JA; Zeitz C
    Hum Mol Genet; 2014 Jan; 23(2):491-501. PubMed ID: 24026677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation.
    Hua M; Williams L; Burns K; Liu S; Ellis J; Innes AM; McPherson M; Yang G
    Stem Cell Res; 2024 Apr; 76():103344. PubMed ID: 38364506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
    Wang H; Luo Y; Li J; Guan J; Yang S; Wang Q
    Stem Cell Res; 2022 Apr; 60():102736. PubMed ID: 35247837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
    Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
    Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
    Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
    Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes.
    Puertas-Neyra K; Coco-Martin RM; Hernandez-Rodriguez LA; Gobelli D; Garcia-Ferrer Y; Palma-Vecino R; Tellería JJ; Simarro M; de la Fuente MA; Fernandez-Bueno I
    Stem Cell Res Ther; 2024 Jul; 15(1):192. PubMed ID: 38956727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of two iPSC lines carrying heterozygous or homozygous nonsense mutation in PROM1 gene from a single family.
    Xu P; Guo F; Xie B; Zhong X
    Stem Cell Res; 2022 Oct; 64():102913. PubMed ID: 36191543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9.
    Sun X; Zhou X; Dong B; Wang C; Xiao X; Wang Y
    Stem Cell Res; 2021 Apr; 52():102230. PubMed ID: 33592566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an induced pluripotent stem cell line LEIi019-A from an early-onset retinal dystrophy patient with the autosomal dominant OTX2 c.259G>A variant.
    Zhang D; Jennings L; Chen SC; Zaw K; Lamey TM; Thompson JA; McLaren TL; Chen FK; McLenachan S
    Stem Cell Res; 2024 Aug; 78():103461. PubMed ID: 38852423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line.
    Howden S; Hosseini Far H; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 Jul; 38():101453. PubMed ID: 31082677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
    Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
    Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
    Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
    Lilianty J; Bateman JF; Lamandé SR
    Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.